CRL
Charles Riv Lab (CRL)
NYSE
$229.80+$0.04 (+0.02%)
Price as of Jul 14, 2026 4:07 AM EDT
  • $11.2B
    Market Cap
  • 45.37%
    1-Year Change
  • Diagnostics & Research
    Industry

Earnings Score

Score: 38
Valuation
CRL
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 77
Valuation
CRL
vs History
vs S&P 500
3-Month Momentum
6.41%
12-Month Momentum
16.87%
3-Month Risk Adjusted Momentum
28.85%
12-Month Risk Adjusted Momentum
38.11%

True Yield

N/A
Valuation
CRL
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
2.75%
Net Debt Paydown Yield
-6.64%

Financial Health Score

Score: 6
Valuation
CRL
vs History
vs S&P 500
Ohlson's O-Score
6